HDAC9 and neoplasm: Further studies on the effects of HDAC inhibitors on the cell cycle indicated that they induce activation of the G2/M checkpoint, which has been suggested to explain why—similarly to chemotherapy—tumor cells are more sensitive to these agents in comparison to normal tissues [121,122].